Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchAspirinAspirin (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Association between prior cardiometabolic therapy and in-hospital mortality in very old patients with type 2 diabetes mellitus hospitalized due to COVID-19. A nationwide observational study in Spain

Ramos-Rincón et al., Research Square, doi:10.21203/rs.3.rs-133358/v1
Dec 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality -29% Improvement Relative Risk Aspirin for COVID-19  Ramos-Rincón et al.  Prophylaxis Is prophylaxis with aspirin beneficial for COVID-19? Retrospective 790 patients in Spain (March - May 2020) Higher mortality with aspirin (p=0.02) c19early.org Ramos-Rincón et al., Research Square, Dec 2020 Favorsaspirin Favorscontrol 0 0.5 1 1.5 2+
Retrospective 790 hospitalized type 2 diabetes patients ≥80 years old in Spain, showing higher mortality with existing aspirin use.
Study covers aspirin and metformin.
risk of death, 28.9% higher, RR 1.29, p = 0.02, treatment 132 of 264 (50.0%), control 253 of 526 (48.1%), adjusted per study, odds ratio converted to relative risk, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ramos-Rincón et al., 28 Dec 2020, retrospective, Spain, preprint, 25 authors, study period 1 March, 2020 - 29 May, 2020. Contact: luismiguelpb1984@gmail.com.
This PaperAspirinAll
DOI record: { "DOI": "10.21203/rs.3.rs-133358/v1", "URL": "http://dx.doi.org/10.21203/rs.3.rs-133358/v1", "abstract": "<jats:title>Abstract</jats:title>\n <jats:p>Background\n\nAdvanced age and diabetes are both associated with poor prognosis in COVID-19. However, the effects of cardiometabolic drugs on the prognosis of diabetic patients with COVID-19, especially very old patients, are not well-known. This work aims to analyze the association between preadmission cardiometabolic therapy (antidiabetic, antiaggregant, antihypertensive, and lipid-lowering drugs) and in-hospital mortality among patients ≥ 80 years with type 2 diabetes mellitus hospitalized for COVID-19.\nMethods\n\nWe conducted a nationwide, multicenter, retrospective, observational study in patients ≥ 80 years with type 2 diabetes mellitus and COVID-19 hospitalized in 160 Spanish hospitals between March 1 and May 29, 2020 who were included in the SEMI-COVID-19 Registry. The primary outcome measure was in-hospital mortality. A multivariate logistic regression analysis were performed to assess the association between preadmission cardiometabolic therapy and in-hospital mortality. The regression analysis values were expressed as adjusted odds ratios (AOR) with a 95% confidence interval (CI). In order to select the variables, the forward selection Wald statistic was used. Discrimination of the fitted logistic model was assessed via a receiver operating characteristic (ROC) curve. The Hosmer-Lemeshow test for logistic regression was used to determine the model’s goodness of fit.\nResults\n\nOf the 2,763 patients ≥80 years old hospitalized due to COVID-19, 790 (28.6%) had T2DM. Of these patients, 385 (48.7%) died during admission. On the multivariate analysis, the use of dipeptidyl peptidase-4 inhibitors (AOR 0.502, 95% CI 0.309–0.815, p = 0.005) and angiotensin receptor blockers (AOR 0.454, 95% CI 0.274–0.759, p = 0.003) were independent protectors against in-hospital mortality whereas the use of acetylsalicylic acid was associated with higher in-hospital mortality (AOR 1.761, 95% CI 1.092–2.842, p = 0.020). Other antidiabetic drugs, angiotensin-converting enzyme inhibitors and statins showed neutral association with in-hospital mortality. The model showed an area under the curve of 0.788.\nConclusions\n\nWe found important differences between cardiometabolic drugs and in-hospital mortality in older patients with type 2 diabetes mellitus hospitalized for COVID-19. Preadmission treatment with dipeptidyl peptidase-4 inhibitors and angiotensin receptor blockers may reduce in-hospital mortality; other antidiabetic drugs, angiotensin-converting enzyme inhibitors and statins seem to have a neutral effect; and acetylsalicylic acid may be associated with excess mortality.</jats:p>", "accepted": { "date-parts": [ [ 2020, 12, 21 ] ] }, "author": [ { "affiliation": [ { "name": "Miguel Hernandez University of Elche: Universidad Miguel Hernandez de Elche" } ], "family": "Ramos-Rincón", "given": "Jose Manuel", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0001-9512-8274", "affiliation": [ { "name": "Hospital Regional Universitario de Málaga: Hospital Regional Universitario de Malaga" } ], "authenticated-orcid": false, "family": "Pérez-Belmonte", "given": "Luis M", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Juan Ramón Jiménez: Hospital Juan Ramon Jimenez" } ], "family": "Carrasco-Sánchez", "given": "Francisco Javier", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Regional Universitario de Málaga: Hospital Regional Universitario de Malaga" } ], "family": "Jansen-Chaparro", "given": "Sergio", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Juan Ramón Jiménez: Hospital Juan Ramon Jimenez" } ], "family": "De-Sousa-Baena", "given": "Mercedes", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Regional Universitario de Málaga: Hospital Regional Universitario de Malaga" } ], "family": "Bueno-Fonseca", "given": "José", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Juan Ramón Jiménez: Hospital Juan Ramon Jimenez" } ], "family": "Pérez-Aguilar", "given": "Maria", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital 12 de Octubre Servicio de Medicina Interna" } ], "family": "Cañas", "given": "Coral Arévalo", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital General Universitario Gregorio Marañón: Hospital General Universitario Gregorio Maranon" } ], "family": "Cebrian", "given": "Marta Bacete", "sequence": "additional" }, { "affiliation": [ { "name": "San Carlos University Hospital Internal Medicine III Service: Hospital Clinico Universitario San Carlos Servicio de Medicina Interna III" } ], "family": "Méndez-Bailón", "given": "Manuel", "sequence": "additional" }, { "affiliation": [ { "name": "Royo Villanova Hospital: Hospital Royo Villanova" } ], "family": "Mera", "given": "Isabel Fiteni", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Ramon y Cajal: Hospital Universitario Ramon y Cajal" } ], "family": "García", "given": "Andrés González", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Costa del Sol" } ], "family": "Romero", "given": "Francisco Navarro", "sequence": "additional" }, { "affiliation": [ { "name": ": Complejo Asistencial de Zamora" } ], "family": "Almeida", "given": "Carlota Tuñón de", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Virgen de la Salud" } ], "family": "Nicolás", "given": "Gemma Muñiz", "sequence": "additional" }, { "affiliation": [ { "name": "Complejo Hospitalario de Orense: Complexo Hospitalario de Ourense" } ], "family": "Noya", "given": "Amara González", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Universitario Son Espases: Hospital Universitari Son Espases" } ], "family": "Milian", "given": "Almudena Hernández", "sequence": "additional" }, { "affiliation": [ { "name": "Complejo Hospitalario Universitario de Badajoz" } ], "family": "García", "given": "Gema María García", "sequence": "additional" }, { "affiliation": [ { "name": "VS Hospital" } ], "family": "Pedrajas", "given": "José Nicolás Alcalá", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Doctor Jose Molina Orosa" } ], "family": "García", "given": "Virginia Herrero", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Universitario Rio Hortega" } ], "family": "Corral-Gudino", "given": "Luis", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital de Blanes" } ], "family": "Casanova", "given": "Pere Comas", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital QuironSalud A Coruña" } ], "family": "Míguez", "given": "Héctor Meijide", "sequence": "additional" }, { "affiliation": [ { "name": "Hospital Universitario Infanta Cristina" } ], "family": "Casas-Rojo", "given": "José Manuel", "sequence": "additional" }, { "affiliation": [ { "name": "Regional University Hospital of Malaga: Hospital Regional Universitario de Malaga" } ], "family": "Gómez-Huelgas", "given": "Ricardo", "sequence": "additional" } ], "container-title": [], "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2020, 12, 28 ] ], "date-time": "2020-12-28T21:58:47Z", "timestamp": 1609192727000 }, "deposited": { "date-parts": [ [ 2021, 3, 17 ] ], "date-time": "2021-03-17T17:11:49Z", "timestamp": 1616001109000 }, "group-title": "In Review", "indexed": { "date-parts": [ [ 2022, 4, 5 ] ], "date-time": "2022-04-05T14:34:08Z", "timestamp": 1649169248491 }, "institution": [ { "name": "Research Square" } ], "is-referenced-by-count": 1, "issued": { "date-parts": [ [ 2020, 12, 28 ] ] }, "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "unspecified", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 12, 28 ] ], "date-time": "2020-12-28T00:00:00Z", "timestamp": 1609113600000 } } ], "link": [ { "URL": "https://www.researchsquare.com/article/rs-133358/v1", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.researchsquare.com/article/rs-133358/v1.html", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "8761", "original-title": [], "posted": { "date-parts": [ [ 2020, 12, 28 ] ] }, "prefix": "10.21203", "published": { "date-parts": [ [ 2020, 12, 28 ] ] }, "publisher": "Research Square Platform LLC", "reference-count": 0, "references-count": 0, "relation": {}, "resource": { "primary": { "URL": "https://www.researchsquare.com/article/rs-133358/v1" } }, "score": 1, "short-title": [], "source": "Crossref", "subtitle": [], "subtype": "preprint", "title": "Association between prior cardiometabolic therapy and in-hospital mortality in very old patients with type 2 diabetes mellitus hospitalized due to COVID-19. A nationwide observational study in Spain", "type": "posted-content" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit